PAD 214 (Naratriptan 1 mg)

Pill imprint PAD 214 has been identified as Naratriptan hydrochloride 1 mg.

Naratriptan is used in the treatment of migraine and belongs to the drug class antimigraine agents. Risk cannot be ruled out during pregnancy. Naratriptan 1 mg is not a controlled substance under the Controlled Substance Act (CSA).

Naratriptan hydrochloride

Imprint:

PAD 214

Strength:

1 mg

Color:

White

Shape:

Round

Availability:

Prescription only

Drug Class:

Antimigraine agents

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Paddock Laboratories, Inc.

National Drug Code (NDC):

00574-0214

Inactive Ingredients:

croscarmellose sodium
lactose anhydrous
magnesium stearate
microcrystalline cellulose
hypromellose
titanium dioxide
triacetin

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.